Blood-Brain Interfaces and Bilirubin-Induced Neurological Diseases

E-ISSN： 1873-4286|15|25|2893-2907

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.25, 2009-09, pp. : 2893-2907

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood-Brain Barrier P450 Enzymes and Multidrug Transporters in Drug Resistance: A Synergistic Role in Neurological Diseases

Current Drug Metabolism, Vol. 12, Iss. 8, 2011-10 ,pp. : 742-749

Bentham Science Publishers

Access to resources Recommend Favorite

Lysosomal Storage Diseases and the Blood-Brain Barrier

Current Pharmaceutical Design, Vol. 14, Iss. 16, 2008-06 ,pp. : 1566-1580

Bentham Science Publishers

Access to resources Recommend Favorite

Ultrasound-Induced Blood-Brain Barrier Opening

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 7, 2012-06 ,pp. : 1332-1345

Bentham Science Publishers

Access to resources Recommend Favorite

Blood-Brain Barrier Transport of Drugs for the Treatment of Brain Diseases

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 3, 2009-07 ,pp. : 195-204

Bentham Science Publishers

Access to resources Recommend Favorite

l-NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice

By Ding-Zhou L. Marchand-Verrecchia C. Croci N. Plotkine M. Margaill I.

European Journal of Pharmacology, Vol. 457, Iss. 2, 2002-12 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite